$116.09 -0.11 (%) Celgene Corp - NASDAQ

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  2. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  3. China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back

    IBD | May. 19, 2015 | 18:54PM EST
  4. Celgene, Lannett Lead Boisterous Day For Drugmakers

    IBD | May. 18, 2015 | 15:56PM EST
  5. Q1 Earnings Drive Industry Group Winners And Losers

    IBD | May. 8, 2015 | 18:59PM EST
  6. Celgene's Earnings Shine While Revenue Misses By An Inch In The First Quarter

    GuruFocus | May. 6, 2015 | 13:02PM EST
  7. Frothy China Or No, World Mutual Funds Topped In April

    IBD | May. 5, 2015 | 18:28PM EST
  8. Growth Names Pressured As IBD 50 Slumps 4% For Week

    IBD | May. 1, 2015 | 18:27PM EST
  9. Nasdaq Hits 5000 As Stocks Soar; JetBlue, Skyworks Take Flight

    IBD | May. 1, 2015 | 15:16PM EST
  10. Analysis of REVLIMID in Patients with Non-Del-5Q MDS Demonstrated Improved Health Related Quality of Life Measures

    Benzinga | May. 1, 2015 | 07:34AM EST
  11. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 18:50PM EST
  12. Gilead EPS Soars Past Views

    IBD | Apr. 30, 2015 | 18:42PM EST
  13. LinkedIn Sinks On Q2 Outlook, But Apple Supplier Skyworks Gains

    IBD | Apr. 30, 2015 | 17:13PM EST
  14. Top-Rated Biotech Unravels Base-Building Effort

    IBD | Apr. 30, 2015 | 16:27PM EST
  15. Stocks Fall Hard, End Near Lows; Biotechs Slammed Again

    IBD | Apr. 30, 2015 | 16:14PM EST
  16. Earnings Torpedo Leading Stocks, But Taser, Oil Drillers Surge

    IBD | Apr. 30, 2015 | 14:54PM EST
  17. Celgene Leads Biotech Decline As Stock Market Remains Lower

    IBD | Apr. 30, 2015 | 13:32PM EST
  18. Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings

    IBD | Apr. 30, 2015 | 10:48AM EST
  19. Celgene Posts Higher Q1 Earnings, But Sales Miss Expectations

    Benzinga | Apr. 30, 2015 | 10:23AM EST
  20. Morning Market Losers

    Benzinga | Apr. 30, 2015 | 10:10AM EST
  21. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 30, 2015 | 08:28AM EST
  22. Biotechs Weigh On Nasdaq, But Apple, Twitter Hold Firm

    IBD | Apr. 27, 2015 | 13:16PM EST
  23. Benzinga's Weekend M&A Chatter

    Benzinga | Apr. 26, 2015 | 19:17PM EST
  24. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  25. Biogen Earnings Preview: What To Look For

    IBD | Apr. 23, 2015 | 19:45PM EST
  26. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD | Apr. 17, 2015 | 20:04PM EST
  27. CELGENE

    IBD | Apr. 15, 2015 | 18:37PM EST
  28. Phase II Data for Apremilast in Behçet's Disease Published in The New England Journal of Medicine

    Benzinga | Apr. 15, 2015 | 17:04PM EST
  29. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD | Mar. 3, 2015 | 17:22PM EST
  30. ABRAXANE Approved by European Commission for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

    Benzinga | Mar. 2, 2015 | 09:56AM EST
  31. Biotech Celgene Thrives On Life-Giving Drugs

    IBD | Feb. 27, 2015 | 18:51PM EST
  32. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD | Feb. 26, 2015 | 09:56AM EST
  33. United Therapeutics Blood Pressure Drug Spurs Q4 Beat

    IBD | Feb. 24, 2015 | 10:04AM EST
  34. Mike Khouw's Celgene Trade

    Benzinga | Feb. 22, 2015 | 20:57PM EST
  35. Celgene Flirting With All-Time Highs

    Benzinga | Feb. 20, 2015 | 11:59AM EST
  36. US Stock Futures Edge Higher Ahead Of Manufacturing PMI

    Benzinga | Feb. 20, 2015 | 07:25AM EST
  37. February Pick Of Biotech Stocks

    GuruFocus | Feb. 17, 2015 | 14:38PM EST
  38. Short Sellers Retreat From Biotech Stocks

    Benzinga | Feb. 12, 2015 | 08:23AM EST
  39. Stocks End Mixed: Molina Healthcare Rises Again

    IBD | Feb. 11, 2015 | 16:22PM EST
  40. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  41. No Deceleration Here: 14 Stocks With Accelerating Profits

    IBD | Feb. 6, 2015 | 18:29PM EST
  42. Celleration Acquisition Just the Start of Alliqua's M&A Strategy

    GuruFocus | Feb. 4, 2015 | 14:18PM EST
  43. Top Performing Funds Favor Leisure, Medical, REITs

    IBD | Feb. 3, 2015 | 18:22PM EST
  44. Biotechs Weigh On Nasdaq; McGraw Hill Rallies

    IBD | Feb. 3, 2015 | 13:30PM EST
  45. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga | Feb. 2, 2015 | 14:26PM EST
  46. Jefferies Raises Price Target On Celgene, Says It Was 'Too Pessimistic'

    Benzinga | Feb. 2, 2015 | 10:38AM EST
  47. Celgene CEO: People And Embracing Change Are The Key To Our Success

    Benzinga | Feb. 2, 2015 | 07:49AM EST
  48. Stocks That Battle Cancer Were The Best-Performing Biotechs In January

    Benzinga | Jan. 30, 2015 | 13:03PM EST
  49. Celgene's EPS Contain 'Few Surprises,' Baird Says

    Benzinga | Jan. 30, 2015 | 12:05PM EST
  50. Alexion Beats Q4 Estimates, Appoints New CEO

    IBD | Jan. 29, 2015 | 13:28PM EST
Trading Center